Alexey A. Plotnikov

Alexey A. Plotnikov

Auto-generated profile, based on publicly available information

Alexey A. Plotnikov

National Research Center for Epidemiology and Microbiology named after the honorary academician N. F. Gamaleya

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Closed access
PDF file
APAlexey A. Plotnikov
Alexey A. Plotnikov
OZOlga N. Zaykova
Olga N. Zaykova
EREkaterina V. Rusakova
Ekaterina V. Rusakova
Tatiana Vladimirovna GrebennikovaTatiana Vladimirovna Grebennikova
Tatiana Vladimirovna Grebennikova
1. Introduction: The search for common patterns of the spread of a number of infectious and noncommunicable diseases has led to a revision of approaches and an expansion of research in the field of specific pathogens, susceptibility of the human body and the society. The scientific area devoted to the influence of social organization on disease transmission is called social epidemiology. Objective: To highlight current directions and trends in social epidemiology. Materials and methods: Using the Google Scholar search platform, PubMed and eLibrary scientific databases, we selected and analyzed 28 foreign and 22 domestic publications, 36 of which were issued in 2014–2024. The selection was based on keywords. Epidemiological studies with small samples were not included. Results: The article presents a comparative analysis of the Western and domestic approaches in social epidemiology and raises problems of the impact of inequality, stress, and state institutions on population health and morbidity. It also outlines current directions of social epidemiology research in the domestic and foreign approaches. An interdisciplinary approach to the study of the epidemiology of infectious and noncommunicable diseases is an integral part of epidemiological surveillance. Empirical research within the framework of current areas of social epidemiology is actively conducted worldwide. Conclusion: Social epidemiology allows comprehensive studies of the impact of economics, psychology, and sociology on the epidemic process, which is important for reducing damages caused by infectious and noncommunicable diseases.

12 May 2025 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
Tatiana Vladimirovna GrebennikovaTatiana Vladimirovna Grebennikova
Tatiana Vladimirovna Grebennikova
OZOlga N. Zaykova
Olga N. Zaykova
APAlexey A. Plotnikov
Alexey A. Plotnikov
LKLyudmila V. Kostina
Lyudmila V. Kostina
YCYana Chernoryzh
Yana Chernoryzh
ЦВЦибезов Валерий Владимирович
Цибезов Валерий Владимирович
Introduction. One of the more promising developments in preventing the spread of infections, including COVID-19, is the production of vaccines based on virus-like particles (VLP). Currently, in the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya of the Ministry of Health of the Russia has developed a VLP-based vaccine against COVID-19. The aim of this study is to evaluate the tolerability, safety and immunogenicity of a new vaccine for the prevention of COVID–19 based on VLP compared with placebo for 21 days after two intramuscular injections in phase I clinical trials. Materials and methods. A double-blind, placebo-controlled study of the tolerability, safety and immunogenicity of a vaccine for the prevention of COVID-19 based on VLP was conducted with a dose of the drug containing 40 and 80 micrograms of antigen, the placebo being 0.9% NaCl. The presence or absence of adverse events (AEs) after vaccination was noted in 180 volunteers aged 18 to 55 years; clinical and biochemical blood parameters, the intensity of humoral and cellular immunity before and after vaccination were assessed using enzyme immunoassay, neutralization reactions, lymphocyte blast transformation reactions and flow cytometry. Results. An analysis of the tolerability and safety of the new COVID-19 VLP-vaccine showed that most adverse events were registered within the first 10 days after vaccination, mainly after the first vaccination. In the period from 11 to 21 days after vaccination, AEs were observed in isolated cases. No deaths, serious or other AEs have been reported. The administration of the studied vaccine to the volunteers had no negative effect on the basic vital signs. A comparative analysis of immunogenicity indicators in volunteers showed that the administration of a vaccine with both an antigen content of 40 µg and an antigen content of 80 µg leads to a pronounced and significant increase in the level of specific immunoglobulins, virus neutralizing antibodies and activation of a cell-mediated immune response. As part of the phase I clinical trials, a dose of 80 µg was selected as optimal. Conclusion. It has been shown that a new vaccine for the prevention of COVID-19 based on VLP with an antigen content of 40 and 80 µg when administered intramuscularly to volunteers does not cause serious adverse events and induces a tense humoral and cellular immune response.

31 December 2024 in PERSONALITY IN A CHANGING WORLD: HEALTH, ADAPTATION, DEVELOPMENT
Verified
Journal Article
Closed access
NGNational Research Center of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya
National Research Center of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya
APA. A. Plotnikov
A. A. Plotnikov
EBE. A. Bryzgalin
E. A. Bryzgalin
LULomonosov Moscow State University
Lomonosov Moscow State University
MPMoscow Institute of Psychology
Moscow Institute of Psychology
AVA. E. Voiskounsky
A. E. Voiskounsky
Vaccination serves as a primary procedure strengthening the body's immune system and population immunity against numerous infectious pathogens. Despite the paramount importance of vaccination for health protection, individuals respond to it differently depending on the specifics of their motivational attitude, which initiates specific vaccination behavior in accordance with the social context (variability in vaccine acceptance, delay or refusal of vaccination). The motivational attitude towards vaccination, primarily determined by the factorial and processual personality determinants (its traits and cognitive-behavioral aspects), is actively and thoroughly studied by Russian-speaking psychologists within the framework of the activity theory. However, the results obtained in this field of research remain disjointed. Thereby, analytical review of relevant material was conducted that was found using search tools from the online library eLibrary.Ru in journals included in the list of the Russian Higher Attestation Commission, as well as in authoritative book publications. A multicomponent structure of the motivational attitude towards vaccination has been identified, which integrates various motivators consolidated by a system of personality potential. This reflects a synergistic complex of volitional self-sufficiency necessary for the supra-situational management of one's health, either directly or indirectly in conjunction with society. It is concluded that the reviewed publications are incomplete and fragmented, which hinders the development of a comprehensive understanding of the intrapersonal factors involved in vaccination (or anti-vaccination) behavior. It is suggested that an incremental approach to identifying such factors and conducting a comprehensive analysis will provide practical benefits in improving healthcare methods to enhance people's predisposition to immunoprophylaxis.

13 March 2026 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
APA. A. Plotnikov
A. A. Plotnikov
YCYana Chernoryzh
Yana Chernoryzh
DVD. I. Vovk
D. I. Vovk
IFI. E. Filatov
I. E. Filatov
Tatiana Vladimirovna GrebennikovaTatiana Vladimirovna Grebennikova
Tatiana Vladimirovna Grebennikova
ЯЧЯ. Ю. Чернорыж
Я. Ю. Чернорыж
Relevance. Psychoneuroimmune aspects of the formation of post-vaccination immunity against SARS-CoV-2 are of particular interest for modern virology and epidemiology. The variability of the individual immune response to vaccination may be associated not only with immunological but also with psychophysiological factors. The aim to evaluate the influence of psychophysiological factors (situational and personal anxiety, awareness of vaccination) on the manifestation of the immune response after immunization with a vaccine for the prevention of COVID-19 based on virus-like particles (VLP), as well as to evaluate the relationships between these factors. Materials and methods. A questionnaire was administered to 248 volunteers aged 18 to 60 years to assess sociodemographic characteristics and analyze the level of awareness of vaccination issues. The level of anxiety was determined by the standardized State-Trait Anxiety Inventory (STAI) questionnaire adapted by C.D. Spielberger. The intensity of humoral immunity was also assessed before and after vaccination using enzyme-linked immunosorbent assay. All data were processed in encrypted form using the V1 cryptographic protocol to ensure blinding of the study. The transfer of intermediate data were carried out in accordance with the approved form provided in the clinical trial protocol. The study was conducted with the voluntary informed consent of the patients. The study protocol was approved at a meeting of the Ethics Council of the Department of Regulation of the Circulation of Medicines and Medical Devices of the Ministry of Health of the Russian Federation (№4293530-25-2ЭС-214.08.2025). Results. In the group of volunteers immunized with the VLP vaccine for COVID-19 prevention, there was a significant increase in the antibody titer (p<0.001), along with an increase in the level of situational anxiety (p<0.001). It is noteworthy that an increase in the antibody level by 4 times or more was noted in 90% of volunteers with a low level of state anxiety, while 100% of volunteers with a high level of state anxiety did not have an increase in the antibody titer. Factor analysis identified two components influencing post-vaccination humoral immunity: 1–"Anxiety", which included personal anxiety and state anxiety before and after vaccination (psychophysiological determinants); 2–"Immune-age profile", which included age and antibody titer level at the time of vaccination (biological determinants). The total cumulative contribution of the two components to the total variance was 59.7%. The increase in antibodies had a negative correlation with age and the initial level of antibodies (τ = -0,267; p < 0,00; 95% CI [-0,379; -0,141]; n = 156), while the anxiety level had a negative correlation with the degree of awareness of vaccination (τ = -0,212; p < 0,001; 95% CI [-0,324; -0,095]; n=156). For the first time, a predictive model based on discriminant analysis was obtained. Group membership by anxiety level was used as a classification criterion, and personal anxiety indicators, degree of awareness and age served as predictors. Conclusion. Elevated situational anxiety at the time of vaccination is a risk factor for a diminished post-vaccination humoral immune response. A predictive model has been developed to assess this risk, with patient knowledge being its key modifiable parameter. Targeted enhancement of knowledge about vaccine prophylaxis serves as a practical tool of a personalized approach, aimed at reducing anxiety and increasing vaccination efficacy. Ultimately, this strategy may boost both individual vaccine uptake and the overall public health impact of immunization programs.